Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization-Reference-Cited by-同舟云学术

Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization

Published:2014-11 Issue: Volume:87 Page:52-62
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Liu Zhaoqiang,Chen Wenmin,Zhan Peng,De Clercq Erik,Pannecouque Christophe,Liu Xinyong

Funder

National Natural Science Foundation of China

Key Project of NSFC for International Cooperation

Doctoral Program of Higher Education of China

Natural Science Foundation of Shandong Province

KU Leuven

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference26 articles.

1. The current status of the NNRTI family of antiretrovirals used in the HAART regime against HIV infection;Martins;Curr. Med. Chem.,2008

2. Design strategies of novel NNRTIs to overcome drug resistance;Zhan;Curr. Med. Chem.,2009

3. HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design;Zhan;Med. Res. Rev.,2013

4. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms;Li;J. Med. Chem.,2012

5. Recent advances in DAPYs and related analogues as HIV-1 NNRTIs;Chen;Curr. Med. Chem.,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal chemistry perspectives on the development of piperazine-containing HIV-1 inhibitors;Bioorganic & Medicinal Chemistry;2024-02

2. N-Phenyl-1-(phenylsulfonyl)-1H-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor;Journal of Medicinal Chemistry;2023-05-02

3. Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors;European Journal of Medicinal Chemistry;2023-03

4. Diarylpyrimidines and related analogs as antiviral agents;Privileged Scaffolds in Drug Discovery;2023

5. Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold—A Short Review of Most Recent Studies 2013–2022;International Journal of Molecular Sciences;2022-08-09